header-logo header-logo

06 June 2025 / Marie Law
Issue: 8119 / Categories: Features , Family , Health
printer mail-detail

*Partner copy* Nailing the evidence

Marie Law, Director of Toxicology at AlphaBiolabs, explores the evidential benefits of nail drug and alcohol testing

As a leading provider of UKAS-accredited drug and alcohol testing, and a trusted training partner of the Judicial College, AlphaBiolabs recently had the opportunity to deliver a session on drug and alcohol testing to over 80 members of the judiciary.

Among the many insightful discussions that took place, there was a noticeable interest in alternative testing methods to complement hair testing – particularly nail testing.

Here, we take a closer look at nail drug and alcohol testing, its evidential value, and how it can be used to support or enhance other toxicology evidence.

What is nail testing and how does it work?

Nail testing is a toxicological method used to detect drug use or, in the case of nail alcohol testing, to monitor abstinence or chronic and excessive alcohol consumption over an extended period.

When a person consumes drugs or alcohol, these substances and their metabolites enter the bloodstream and become embedded in the keratin fibres of the nails as they grow (see box outs). Once deposited, these markers remain stable, providing a retrospective overview of substance use.

  • Fingernail clippings offer an overview detection window of up to approximately 6 months
  • Toenails grow slower than fingernails, so toenail clippings can provide an overview detection window of up to approximately 12 months
  • As only nail clippings are required, sample collection is non-invasive and can be conducted discreetly. This makes nail testing a practical option across a range of legal and social care settings

When is nail testing appropriate?

Nail testing is especially useful when hair testing is unavailable or unsuitable. Common scenarios include:

  • Absence or insufficiency of head hair (e.g. due to shaving, alopecia, or cultural/religious practices)
  • Cases requiring corroborative evidence alongside behavioural or clinical assessments
  • Suspected adulteration of hair samples, where bleaching, dyeing or excessive washing may compromise results

In such instances, nail testing provides a robust alternative. It is also highly relevant in child protection cases, where long-term patterns of drug or alcohol use need to be evidenced swiftly to inform safeguarding decisions.

Complementary use

While nail testing can be conducted independently, its evidential power is amplified when used in conjunction with other testing methods. Combining nail drug or alcohol testing with hair, blood, urine or oral fluid analysis allows legal professionals to:

  • Cross-verify findings across biological matrices
  • Extend the overall detection window (e.g. 6cm hair = 6 months + toenail clippings = up to 12 months)
  • Support or challenge self-reported histories of abstinence or misuse

In alcohol testing, nail samples can complement blood biomarker testing – such as phosphatidylethanol (PEth) – to build a multi-source profile of alcohol use (proof of abstinence or supportive of chronic and excessive use). This is particularly valuable in care proceedings where establishing long-term parental behaviour is critical.

Understanding your options for drug and alcohol testing

As toxicological science evolves, it’s essential for the legal profession to remain up to date on the full range of testing options available, particularly when decisions in court can have far-reaching consequences for families.

Nail testing offers a reliable means of evidencing long-term substance use, and is effective as:

  • a standalone option, when other sample types are not viable
  • part of a multi-matrix testing strategy, to provide a more comprehensive evidential picture

Want to learn more? Register now for our FREE 40-minute webinar, The Right Test at the Right Time: drug & alcohol testing for every scenario, on Tuesday 17 June at 1pm and Thursday 19 June at 9am. alphabiolabs.co.uk/learning-centre/webinars

For more information or to request a quote, contact our New Enquiry team on 0333 600 1300 / testing@alphabiolabs.com or visit www.alphabiolabs.co.uk.

Marie Law, Director of Toxicology at AlphaBiolabs
A highly-skilled and respected scientist with over 15 years’ experience in the field of forensics, Marie joined AlphaBiolabs in 2022 and oversees the company’s growing toxicology team.
As Director of Toxicology, Marie’s day-to-day responsibilities include maintaining the highest quality testing standards for toxicology and further enhancing AlphaBiolabs’ drug and alcohol testing services for the legal sector, members of the public, and the workplace sector.

MOVERS & SHAKERS

Sidley—James Inness

Sidley—James Inness

Partner joins capital markets team in London office

Haynes Boone—William Cecil

Haynes Boone—William Cecil

Firm announces appointment of partner as UK general counsel

Devonshires—Nicholas Barrows

Devonshires—Nicholas Barrows

Firm appoints first chief marketing officer to drive growth strategy

NEWS
A seemingly dry procedural update may prove potent. In his latest 'Civil way' column for NLJ this week, Stephen Gold explains that new CPR 31.12A—part of the 193rd update—fills a ‘lacuna’ exposed in McLaren Indy v Alpa Racing
The long-running Mazur saga edged towards its finale as the Court of Appeal heard arguments on whether non-solicitors can ‘conduct litigation’. Writing in NLJ this week, Professor Dominic Regan of City Law School reports from a packed courtroom where 16 wigs watched Nick Bacon KC argue that Mr Justice Sheldon had failed to distinguish between ‘tasks and responsibilities’

The Court of Appeal has slammed the brakes on claimants trying to swap defendants after limitation has expired. In Adcamp LLP v Office Properties and BDB Pitmans v Lee [2026] EWCA Civ 50, it overturned High Court rulings that had allowed substitutions under s 35(6)(b) of the Limitation Act 1980, reports Sarah Crowther of DAC Beachcroft in this week's NLJ

Cheating in driving tests is surging—and courts are responding firmly. Writing in NLJ this week, Neil Parpworth of De Montfort Law School charts a rise in impersonation and tech-assisted fraud, with 2,844 attempts recorded in a year
As AI-generated ‘deepfake’ images proliferate, the law may already have the tools to respond. In NLJ this week, Jon Belcher of Excello Law argues that such images amount to personal data processing under UK GDPR
back-to-top-scroll